Investors Meet Thirty of Top Startups in America-Angel Venture TUE, OCT 13 2020 9:00 AM—FRI, OCT 30 2020 4:00 PM SFA Therapeutics has been selected to present at the The 24th annual Angel Venture [...]
The orphan drug designation will provide SFA Therapeutics with significant drug development and tax advantages as well as an expanded period of market exclusivity. Link to Press Release
SFA Therapeutics’ CEO Dr Ira Spector presents an overview of the company and its platform technology SFA Overview Presentation on YouTube Introduction to SFA Liver Disease and Oncology [...]
Interview with SFA Therapeutics CEO on Money Matters TV- Charlie Huntington of Life Sciences Pa and Kimon Hatza, Esq. of MillCrest Law, LLP talk with Ira Spector, Ph. D. CEO of SFA Therapeutics [...]
